Lexington, KYNCT06989853Now EnrollingIRB Ready

Methamphetamine Use Disorder Clinical Trial in Lexington, KY

Access cutting-edge methamphetamine use disorder treatment through this clinical trial at a research site in Lexington. Study-provided care at no cost to qualified participants.

Sponsored by William Stoops

Quick Self-Assessment

See if you qualify for this Lexington location

Preparing your pre-screening questions…

Expert Care in Lexington

Access methamphetamine use disorder specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related methamphetamine use disorder treatment provided free

Apply for This Lexington Location

Check if you qualify for this methamphetamine use disorder clinical trial in Lexington, KY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Lexington

    Convenient for KY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Lexington site if eligible
  4. 4Begin participation

About This Methamphetamine Use Disorder Study in Lexington

This will be a human laboratory study evaluating the influence of troriluzole treatment on the effects of methamphetamine. Supported by and included in the Helping to End Addiction Long-term® (HEAL) Initiative.

Sponsor: William Stoops

Who Can Participate

Inclusion Criteria

able to speak/read English,
not seeking treatment for drug use at the time of the study,
female or male between the ages of 18 and 55 years,
recent methamphetamine use verified by methamphetamine positive urine, as well as fulfillment of DSM-5 diagnostic criteria for MUD,
judged to be medically and psychiatrically healthy by study physicians other than the diagnosis for MUD (and OUD for the co-morbid MUD and OUD group, see below) at the time of screening,
ECG, read by a cardiologist, within normal limits,
females using an effective form of birth control and not pregnant or breastfeeding,
no known contraindications (e.g., hepatic disease \[save for asymptomatic HCV status as cleared by study physician\]) or allergies to troriluzole. Individuals in the MUD and OUD group must also report recent opioid use, verified by opioid positive urine, as well as fulfillment of DSM-5 diagnostic criteria for OUD with physiologic dependence (determined to not be physically dependent if a participant arrives with a urine sample for drug screening that is negative for a short-acting opioid and does not have a score of 5 or greater on the clinical opioid withdrawal scale \[COWS\]).

Exclusion Criteria

unable to speak/read English,
seeking treatment for drug use,
under 18 years or over 55 years,
no recent methamphetamine use as indicated by methamphetamine negative urine and no DSM-5 diagnosis of MUD,
judged to be medically and psychiatrically unhealthy by study physicians at the time of screening,
ECG, read by a cardiologist, outside normal limits,
females not using an effective form of birth control or pregnant or breastfeeding,
blood pressure readings indicative of hypertension (i.e., blood pressure \> 140/90 mmHg) on 2 consecutive screening visits,
BMI \< 18 or \> 30; weight \< 50 kg,
taking any medications prescribed by a physician for a chronic condition,
any laboratory chemistry values (e.g., LFTs) \> 3 times normal at screening or during admission,
history of serious physical disease or diagnosis of any disorder (e.g., current hepatic disease \[save for asymptomatic HCV status; as noted above\], histories of seizure, diabetes, asthma or CNS tumors) or current or past histories of psychiatric disorder, including current or recent suicidal ideation that would limit compliance in the study, other than MUD or tobacco use disorder (and OUD for the co-morbid MUD/OUD group only) that in the opinion of the study physicians would interfere with participation and
contraindications (e.g., hepatic disease) or allergies to troriluzole.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Lexington?

Yes, this clinical trial (NCT06989853) has an active research site in Lexington, KY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Methamphetamine Use Disorder Treatment Options in Lexington, KY

If you're searching for methamphetamine use disorder treatment options in Lexington, KY, this clinical trial (NCT06989853) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Lexington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced methamphetamine use disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all methamphetamine use disorder clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Lexington, KY

See all heart attack clinical trials recruiting in Lexington — not just this study.

Browse Heart Attack Trials in Lexington →

Browse More Trials by Condition

Heart Attack TrialsEssential Tremor TrialsPulmonary Hypertension TrialsMyocardial Infarction TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Lexington?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Lexington, KY